Literature DB >> 12872157

A conserved amphipathic helix in WASP/Scar proteins is essential for activation of Arp2/3 complex.

Sanjay C Panchal1, Donald A Kaiser, Eduardo Torres, Thomas D Pollard, Michael K Rosen.   

Abstract

Members of the Wiskott-Aldrich syndrome protein (WASP) family link Rho GTPase signaling pathways to the cytoskeleton through a multiprotein assembly called Arp2/3 complex. The C-terminal VCA regions (verprolin-homology, central hydrophobic, and acidic regions) of WASP and its relatives stimulate Arp2/3 complex to nucleate actin filament branches. Here we show by differential line broadening in NMR spectra that the C (central) and A (acidic) segments of VCA domains from WASP, N-WASP and Scar bind Arp2/3 complex. The C regions of these proteins have a conserved sequence motif consisting of hydrophobic residues and an arginine residue. Point mutations in this conserved sequence motif suggest that it forms an amphipathic helix that is required in biochemical assays for activation of Arp2/3 complex. Key residues in this motif are buried through contacts with the GTPase binding domain in the autoinhibited structure of WASP and N-WASP, indicating that sequestration of these residues is an important aspect of autoinhibition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872157     DOI: 10.1038/nsb952

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  70 in total

1.  A novel phospholipase D2-Grb2-WASp heterotrimer regulates leukocyte phagocytosis in a two-step mechanism.

Authors:  Samuel Kantonen; Nathaniel Hatton; Madhu Mahankali; Karen M Henkels; Haein Park; Dianne Cox; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  Isoform diversity in the Arp2/3 complex determines actin filament dynamics.

Authors:  Jasmine V G Abella; Chiara Galloni; Julien Pernier; David J Barry; Svend Kjær; Marie-France Carlier; Michael Way
Journal:  Nat Cell Biol       Date:  2015-12-14       Impact factor: 28.824

Review 3.  The state of the filament.

Authors:  Adeleke H Aguda; Leslie D Burtnick; Robert C Robinson
Journal:  EMBO Rep       Date:  2005-03       Impact factor: 8.807

4.  Actin binding to the central domain of WASP/Scar proteins plays a critical role in the activation of the Arp2/3 complex.

Authors:  Alexander E Kelly; Heather Kranitz; Volker Dötsch; R Dyche Mullins
Journal:  J Biol Chem       Date:  2005-12-23       Impact factor: 5.157

5.  Visualizing Arp2/3 complex activation mediated by binding of ATP and WASp using structural mass spectrometry.

Authors:  Janna G Kiselar; Rachel Mahaffy; Thomas D Pollard; Steven C Almo; Mark R Chance
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

6.  Unfolding of the C-terminal domain of the J-protein Zuo1 releases autoinhibition and activates Pdr1-dependent transcription.

Authors:  Jeanette K Ducett; Francis C Peterson; Lindsey A Hoover; Amy J Prunuske; Brian F Volkman; Elizabeth A Craig
Journal:  J Mol Biol       Date:  2012-10-02       Impact factor: 5.469

Review 7.  Grab your partner with both hands: cytoskeletal remodeling by Arp2/3 signaling.

Authors:  Scott H Soderling
Journal:  Sci Signal       Date:  2009-01-27       Impact factor: 8.192

8.  Nucleotide- and activator-dependent structural and dynamic changes of arp2/3 complex monitored by hydrogen/deuterium exchange and mass spectrometry.

Authors:  Wendy D Zencheck; Hui Xiao; Brad J Nolen; Ruth Hogue Angeletti; Thomas D Pollard; Steven C Almo
Journal:  J Mol Biol       Date:  2009-03-17       Impact factor: 5.469

9.  Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses.

Authors:  Jun Komano; Kosuke Miyauchi; Zene Matsuda; Naoki Yamamoto
Journal:  Mol Biol Cell       Date:  2004-09-22       Impact factor: 4.138

10.  Structural basis of actin sequestration by thymosin-beta4: implications for WH2 proteins.

Authors:  Edward Irobi; Adeleke H Aguda; Mårten Larsson; Christophe Guerin; Helen L Yin; Leslie D Burtnick; Laurent Blanchoin; Robert C Robinson
Journal:  EMBO J       Date:  2004-08-26       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.